A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/519 (2006.01) A61K 31/496 (2006.01) A61K 31/505 (2006.01) A61K 38/49 (2006.01) A61K 45/06 (2006.01) A61P 1/04 (2006.01)
Patent
CA 2415791
This invention relates to the use of cyclic guanosine 3', 5'-monophosphate type five (cGMP PDE5) inhibitors (hereinafter PDE5 inhibitors), including in particular the compound sildenafil, for the treatment of chronic wounds of a non-diabetic origin including in particular chronic venous ulcers, chronic decubitus (pressure sores ) and arterial ulcers; and acute wounds.
L'invention se rapporte à l'utilisation d'inhibiteurs de la guanosine 3'5'-monophosphate cyclique de type cinq (cGMP PDE5) (ci-après dénommés inhibiteurs PDE5), y compris, en particulier, le composé sildenafil, pour le traitement de blessures chroniques d'origine non diabétique (notamment les ulcères veineux chroniques, les ulcères de décubitus chroniques (plaies de lit) et les ulcères artériels), et de blessures aiguës.
Davies Michael John
Huggins Jonathan Paul
Parums Dinah Velta
Pfizer Inc.
Smart & Biggar
LandOfFree
Treatment of wounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of wounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of wounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1978017